Meet Herriot Tabuteau, The Haitian-Born Doctor Whose Brain Disorder Medications Turned Into A $6 Billion Empire
With shares continuing to climb, reaching 35% to $122, outperforming the Nasdaq Biotech Index, Tabuteau and Axsome have no plans on stopping.